- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03728517
Narcotics Inpatient / Outpatient
Comparison of Inpatient Narcotics Use to Outpatient Prescription Narcotics Post-operatively
Managing pain in postoperative patients presents challenges in striking a balance between achieving adequate pain control and over-prescribing opioids that have the potential to contribute to the opioid epidemic. There are no clear guidelines informing postoperative opioid prescribing in obstetrics and gynecology.
The primary aim for this study are to better understand the factors that impact opioid use for pain management in gynecologic surgery patient after discharge. The second aim is to develop a model that incorporates individual patient baseline measures (e.g. anxiety, fibromyalgia score, inpatient narcotic consumption) to predict the amount of opioids needed following discharge.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Managing pain in postoperative patients presents challenges in striking a balance between achieving adequate pain control and over-prescribing opioids that have the potential to contribute to the opioid epidemic. There are no clear guidelines informing postoperative opioid prescribing in obstetrics and gynecology. A recent study by As-Sanie et al. demonstrated that gynecologists at a large academic medical center prescribe twice the amount of opioids than the average patient uses after hysterectomy.1 Similarly, a study completed at Vanderbilt University Medical Center showed that obstetricians were overprescribing narcotics to patients after cesarean deliveries.2
In addition to rates of opioid prescribing, other factors affect postoperative opioid consumption, including individual patient measures of anxiety, depression, and self-reported pain scores prior to surgery. Preoperative Fibromyalgia symptom scores, STAIT state anxiety scores and NRS pain expectations are independent predictors for morphine consumption following hysterectomy.
There is a pressing need to better understand the factors that impact opioid use in women who undergo gynecologic surgery in order to mitigate the over-use of opioids for pain control upon discharge from the hospital.
Aims:
Understand the factors that impact opioid use for pain management in gynecologic surgery patients after discharge.
- Is opioid consumption during the immediate postoperative recovery phase associated with consumption after discharge?
- Are variables that are known to be associated with opioid consumption, also associated with opioid consumption after discharge?
- Are there factors which we can use to predict opioid consumption in postoperative patients?
- Develop a model that incorporates individual patient baseline measures (e.g. anxiety, fibromyalgia score, inpatient narcotic consumption) to predict the amount of opioids needed following discharge.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Indiana
-
Indianapolis, Indiana, Verenigde Staten, 46202
- Indiana University
-
Indianapolis, Indiana, Verenigde Staten, 46202
- Methodist Hospital
-
Indianapolis, Indiana, Verenigde Staten, 46202
- Eskenazi Health Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- 18 years old or older
- Undergoing vaginal, laparoscopic or robotic gynecologic surgery requiring observation or inpatient stay overnight
- Agree to receiving contact from research staff for follow up
- Can provide two telephone numbers or a telephone number and email address
Exclusion Criteria:
- Unable to provide informed consent
- Age <18
- Intolerance/allergy to more than two narcotic medications
- Allergy/contraindication to non-steroidal anti-inflammatory drugs (NSAIDs)
- Has a diagnosed gynecologic malignancy other than Grade 1 endometrial cancer
- Pregnant
- Current opioid use on a regular basis (more than twice per week)
- Illicit drug-use within the past 30 days
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Cohort
- Tijdsperspectieven: Prospectief
Cohorten en interventies
Groep / Cohort |
|---|
|
Subjects who undergo gynecologic surgery
Subjects who will undergo gynecologic surgery via vaginally, laparoscopic , or robotic who require observation or inpatient stay overnight.
This group will receive pain medication in the hospital and will also be discharged home with pain medication.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Understand the factors that impact opioid use for pain management in gynecologic surgery patients after discharge.
Tijdsspanne: 1 year
|
|
1 year
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Develop a model
Tijdsspanne: 1 year
|
2. Develop a model that incorporates individual patient baseline measures (e.g.
anxiety, fibromyalgia score, inpatient narcotic consumption) to predict the amount of opioids needed following discharge.
|
1 year
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Insiyyah Y Patanwala, Indiana School of Medicine
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 1805708779
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .